HERPES SIMPLEX 1 VIRCLIA®IGG/IGM MONOTEST - COFEPRIS Registration 1402R2021 SSA
Access comprehensive regulatory information for HERPES SIMPLEX 1 VIRCLIA®IGG/IGM MONOTEST (HERPES SIMPLEX 1 VIRCLIA®IGG/IGM MONOTEST) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1402R2021 SSA and manufactured by KABLACOMERCIAL,S.A.DE C.V.. The device was registered on September 13, 2021.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
HERPES SIMPLEX 1 VIRCLIA MONOTESTIGG/IGM ES UN INMUNOENSAYOQUIMIOLUMINISCENTE INDIRECTO (CLIA)PARADETERMINARANTICUERPOSIGGOIGMESPECÍFICOS A HERPES SIMPLEX TIPO 1 ENSUERO O PLASMA.
HERPES SIMPLEX 1 VIRCLIA MONOTESTIGG/IGM IS AN INDIRECT CHEMILUMINESCENT IMMUNOASSAY (CLIA) TO DETERMINESIGGOIGMSPECIFIC ANTIBODIES TO HERPES SIMPLEX TYPE 1 SERUM OR PLASMA.